-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Abivax to Hold, Lowers Price Target to $90

Benzinga·06/02/2026 15:17:18
Listen to the news
Jefferies analyst Faisal Khurshid downgrades Abivax (NASDAQ:ABVX) from Buy to Hold and lowers the price target from $160 to $90.